Managing patients with PCSK9 inhibitors: navigating the continuum of cardiovascular risk.

1 September 2020 (15:08 - 15:14)

Organised by:

About the speaker

Professor Gaetano Maria De Ferrari

University of Turin, Turin (Italy)

4 More presentations in this session

Presentation thumbnail

PCSK9 inhibitors from bench to real world: a journey to improve CV outcomes in very high-risk patients. - Sponsored by Amgen (Europe) GmbH.

Presentation thumbnail

PCSK9 inhibitors: from pre-clinical research to clinical practice.

Professor C. Ballantyne (Houston, US)

Presentation thumbnail

PCSK9 inhibitors: what can we learn from 5 years of real-world use? EU data.

Professor K. Ray (London, GB)

Presentation thumbnail

PCSK9 inhibitors: what can we learn from 5 years of real-world use? US/Canadian data.

Professor S. Goodman (Toronto, CA)

Access the full session

Session thumbnail

PCSK9 inhibitors from bench to real world: a journey to improve CV outcomes in very high-risk patients

The Event

ESC Congress 2020

1 September 2020 15:08 CET

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources